TG-100435 is a multitargeted, orally active protein tyrosine kinase inhibitor, with K i of 13 to 64 nM for Src , Lyn , Abl , Yes , Lck , and EphB4 . TG-100435 plays an important role in cancer research.
Products | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Src | Products > Signaling Pathways > Bcr-Abl | Products > Signaling Pathways > Ephrin Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.